PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Research, Kaiser Permanente Northern California, Oakland, CA.\', \'The Permanente Medical Group, Oakland, CA.\', \'Department of Psychiatry and Behavioral Sciences, Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA.\', \'Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA.\', \'Departments of Psychiatry and Epidemiology, Columbia University Irving Medical Center and New York State Psychiatric Institute, New York, NY.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1097/MD.0000000000027664
?:hasPublicationType
?:journal
  • Medicine
is ?:pmid of
?:pmid
?:pmid
  • 34713861
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.105
?:rankingScore_hIndex
  • 4
?:title
  • Psychotropic medication prescribing during the COVID-19 pandemic.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all